Analytical sensitivity and stability of DNA methylation testing in stool samples for colorectal cancer detection.

作者: Linda J. W. Bosch , Sandra Mongera , Jochim S. Terhaar sive Droste , Frank A. Oort , Sietze T. van Turenhout

DOI: 10.1007/S13402-012-0092-6

关键词: DNADNA extractionA-DNAColorectal cancerMethylationControl subjectsMolecular biologyDNA methylationChemistryPositive test

摘要: Stool-based molecular tests hold large potential for improving colorectal cancer screening. Here, we investigated the analytical sensitivity of a DNA methylation assay on partial stool samples, and estimated degradation in over time. In addition, explored detection fecal immunochemical test (FIT) fluid. Partial samples colonoscopy-negative individuals were homogenized with homogenization buffer, spiked different numbers HCT116 colon cells kept at room temperature 0, 24, 48, 72 144 h before isolation. Analytical was determined by lowest number that yielded positive results or mutation analysis. FIT fluid measured 11 CRC patients 20 control subjects. The detecting 3000 per gram stool, compared to 60000 mutations same samples. No up 72 h noted when conservation buffer used. detected 4/11 none Methylation based testing showed high tumor which hardly influenced time, provided an adequate feasibility demonstrates opportunity combine occult blood collection device.

参考文章(27)
Giuseppe Giaccone, Katrien Grünberg, Mariëlle I. Gallegos Ruiz, Karijn Floor, José A Rodriguez, Frank Rijmen, EGFR and K-ras mutation analysis in non-small cell lung cancer: comparison of paraffin embedded versus frozen specimens. Analytical Cellular Pathology. ,vol. 29, pp. 257- 264 ,(2007) , 10.1155/2007/568205
Y.-X. Luo, D.-K. Chen, S.-X. Song, L. Wang, J.-P. Wang, Aberrant methylation of genes in stool samples as diagnostic biomarkers for colorectal cancer or adenomas: A meta‐analysis International Journal of Clinical Practice. ,vol. 65, pp. 1313- 1320 ,(2011) , 10.1111/J.1742-1241.2011.02800.X
Thomas F. Imperiale, David F. Ransohoff, Steven H. Itzkowitz, Barry A. Turnbull, Michael E. Ross, Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. The New England Journal of Medicine. ,vol. 351, pp. 2704- 2714 ,(2004) , 10.1056/NEJMOA033403
Zohar Levi, Paul Rozen, Rachel Hazazi, Alex Vilkin, Amal Waked, Eran Maoz, Shlomo Birkenfeld, Moshe Leshno, Yaron Niv, A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Annals of Internal Medicine. ,vol. 146, pp. 244- 255 ,(2007) , 10.7326/0003-4819-146-4-200702200-00003
Myoung Sook Kim, Joost Louwagie, Beatriz Carvalho, Jochim S. Terhaar sive Droste, Hannah Lui Park, Young Kwang Chae, Keishi Yamashita, Junwei Liu, Kimberly Laskie Ostrow, Shizhang Ling, Rafael Guerrero-Preston, Semra Demokan, Zubeyde Yalniz, Nejat Dalay, Gerrit A. Meijer, Wim Van Criekinge, David Sidransky, Promoter DNA Methylation of Oncostatin M receptor-β as a Novel Diagnostic and Therapeutic Marker in Colon Cancer PLoS ONE. ,vol. 4, pp. e6555- ,(2009) , 10.1371/JOURNAL.PONE.0006555
Jeff Olson, Duncan H Whitney, Kristine Durkee, Anthony P Shuber, DNA stabilization is critical for maximizing performance of fecal DNA-based colorectal cancer tests. Diagnostic Molecular Pathology. ,vol. 14, pp. 183- 191 ,(2005) , 10.1097/01.PAS.0000176768.18423.7E
David A. Ahlquist, Joel E. Skoletsky, Kevin A. Boynton, Jonathan J. Harrington, Douglas W. Mahoney, William E. Pierceall, Stephen N. Thibodeau, Anthony P. Shuber, Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology. ,vol. 119, pp. 1219- 1227 ,(2000) , 10.1053/GAST.2000.19580
Johann C. Brandes, Manon van Engeland, Kim A.D. Wouters, Matty P. Weijenberg, James G. Herman, CHFR promoter hypermethylation in colon cancer correlates with the microsatellite instability phenotype. Carcinogenesis. ,vol. 26, pp. 1152- 1156 ,(2005) , 10.1093/CARCIN/BGI058
Frank Diehl, Kerstin Schmidt, Kristine H. Durkee, Kent J. Moore, Steve N. Goodman, Anthony P. Shuber, Kenneth W. Kinzler, Bert Vogelstein, Analysis of mutations in DNA isolated from plasma and stool of colorectal cancer patients. Gastroenterology. ,vol. 135, pp. 489- 498 ,(2008) , 10.1053/J.GASTRO.2008.05.039
Maarten L. Janmaat, José A. Rodriguez, Mariëlle Gallegos-Ruiz, Frank A.E. Kruyt, Giuseppe Giaccone, Enhanced cytotoxicity induced by gefitinib and specific inhibitors of the Ras or phosphatidyl inositol‐3 kinase pathways in non‐small cell lung cancer cells International Journal of Cancer. ,vol. 118, pp. 209- 214 ,(2006) , 10.1002/IJC.21290